The lipid droplet protein DHRS3 is a regulator of melanoma cell state

Eleanor Johns,Yilun Ma,Pakavarin Louphrasitthipol,Christopher Peralta,Miranda V. Hunter,Jeremy H. Raymond,Henrik Molina,Colin R. Goding,Richard M. White

DOI: https://doi.org/10.1101/2024.03.25.586589

2024-03-28

Abstract:Lipid droplets are fat storage organelles composed of a protein envelope and lipid rich core. Regulation of this protein envelope underlies differential lipid droplet formation and function. In melanoma, lipid droplet formation has been linked to tumor progression and metastasis, but it is unknown whether lipid droplet proteins play a role. To address this, we performed proteomic analysis of the lipid droplet envelope in melanoma. We found that lipid droplet proteins were differentially enriched in distinct melanoma states; from melanocytic to undifferentiated. DHRS3, which converts all-trans-retinal to all-trans-retinol, is upregulated in the MITF /undifferentiated/neural crest-like melanoma cell state and reduced in the MITF /melanocytic state. Increased DHRS3 expression is sufficient to drive MITF /melanocytic cells to a more undifferentiated/invasive state. These changes are due to retinoic acid mediated regulation of melanocytic genes. Our data demonstrate that melanoma cell state can be regulated by expression of lipid droplet proteins which affect downstream retinoid signaling.

Cancer Biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the role of lipid droplet proteins in the state of melanoma cells, particularly how the DHRS3 protein influences the state transition of melanoma cells by regulating the retinol signaling pathway. Specifically, the researchers focus on:

1. **The role of lipid droplet proteins in melanoma**: The researchers aim to understand the differential expression of lipid droplet proteins in various melanoma cell states (such as differentiated, undifferentiated, and neural crest-like) through proteomic analysis, and whether these differences are related to tumor progression and metastasis.

2. **The function of the DHRS3 protein**: Special attention is given to the DHRS3 protein, an enzyme that converts all-trans-retinal to all-trans-retinol. The study found that DHRS3 is highly expressed in undifferentiated/neural crest-like melanoma cells and lowly expressed in differentiated melanoma cells. The researchers further explored how DHRS3 promotes the transition of melanoma cells to an undifferentiated/invasive state by affecting the retinol signaling pathway.

3. **Regulatory mechanisms of the retinol signaling pathway**: The researchers investigated how DHRS3 regulates the levels of retinol, thereby affecting the activity of retinol receptors (RAR/RXR), ultimately leading to changes in the state of melanoma cells. They also discovered the negative regulatory effect of MITF (a key transcription factor) on DHRS3 expression, further revealing the complex mechanisms of melanoma cell state transition.

Overall, this paper aims to provide new insights into the cellular plasticity of melanoma and potential therapeutic strategies by deeply studying the role of the lipid droplet protein DHRS3 in the state of melanoma cells.